Pérez Gutiérrez, R.M.; Téllez Gómez, J.; Mota Flores, J.M.; Corea Téllez, M.; Muñiz RamÃrez, A.
Baicalin–Myricetin-Coated Selenium Nanoparticles Mitigate Pathology in an Aβ1-42 Mice Model of Alzheimer’s Disease. Pharmaceuticals 2025, 18, 1391.
https://doi.org/10.3390/ph18091391
AMA Style
Pérez Gutiérrez RM, Téllez Gómez J, Mota Flores JM, Corea Téllez M, Muñiz RamÃrez A.
Baicalin–Myricetin-Coated Selenium Nanoparticles Mitigate Pathology in an Aβ1-42 Mice Model of Alzheimer’s Disease. Pharmaceuticals. 2025; 18(9):1391.
https://doi.org/10.3390/ph18091391
Chicago/Turabian Style
Pérez Gutiérrez, Rosa Martha, Julio Téllez Gómez, José MarÃa Mota Flores, Mónica Corea Téllez, and Alethia Muñiz RamÃrez.
2025. "Baicalin–Myricetin-Coated Selenium Nanoparticles Mitigate Pathology in an Aβ1-42 Mice Model of Alzheimer’s Disease" Pharmaceuticals 18, no. 9: 1391.
https://doi.org/10.3390/ph18091391
APA Style
Pérez Gutiérrez, R. M., Téllez Gómez, J., Mota Flores, J. M., Corea Téllez, M., & Muñiz RamÃrez, A.
(2025). Baicalin–Myricetin-Coated Selenium Nanoparticles Mitigate Pathology in an Aβ1-42 Mice Model of Alzheimer’s Disease. Pharmaceuticals, 18(9), 1391.
https://doi.org/10.3390/ph18091391